Condition

MS

ClinicalTrials.gov condition label

Clinical trials9

Recruiting1

Common interventions11

Lead sponsors shown8

Clinical trials

9 shown

"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MSNCT07222618 · 2025-10-01

KYSA-7: A Study of Anti-CD19 CAR T-Cell Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple SclerosisNCT06384976 · 2024-09-20

ACTIVE_NOT_RECRUITING

A Closed Loop, Doctor to Patient, Mobile Application for Depression in People With Multiple SclerosisNCT05865405 · 2023-08-01

ACTIVE_NOT_RECRUITING

Blood Flow Restriction Training in Multiple SclerosisNCT06143930 · 2023-07-01

Macromolecular Imaging of White and Gray Matter Pathology in Multiple SclerosisNCT04415372 · 2021-11-19

ENROLLING_BY_INVITATION

A Pilot Study to Explore the Role of Gut Flora in Multiple SclerosisNCT04148313 · 2020-03-02

Evaluating Multiple Sclerosis Patients ShOWing A GEnomic Signature of Therapy ResponseNCT03316404 · 2017-11-07

Robotics for Mobility Rehabilitation in MSNCT05102682 · 2017-03-10

Treatment Adherence When Using RebiSmart™ in Relapsing Multiple Sclerosis SubjectsNCT01128075 · 2009-08-01

Common interventions

Anti-CD20 mABDRUG1 Balance exercise program using exoskeleton deviceOTHER1 KYV-101BIOLOGICAL1 MRIDIAGNOSTIC_TEST1 MS CATCHBEHAVIORAL1 Neuropsychological TestingDIAGNOSTIC_TEST1 No InterventionOTHER1 RebiSmart™DEVICE1 Standard lymphodepletion regimenDRUG1 strengthening exOTHER1 strengthening ex with BFR trainingOTHER1

Leading sponsors

University of California, San Francisco2 Cairo University1 DxTerity Diagnostics1 East Kent Hospitals University NHS Foundation Trust1 Kyverna Therapeutics1 Merck KGaA, Darmstadt, Germany1 ProgenaBiome1 University of Wisconsin, Madison1

Trial status mix

COMPLETED3

ACTIVE_NOT_RECRUITING2

ENROLLING_BY_INVITATION1

RECRUITING1

UNKNOWN1

WITHDRAWN1

Phase mix

NA2

PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.